Patrick McGorry

Last updated

Patrick McGorry

AO
Patrick McGorry 2010.jpg
McGorry in 2010
Born (1952-09-10) 10 September 1952 (age 71)
Dublin, Ireland
NationalityAustralian
Education Bishop Gore School
Newcastle Boys' High School
Alma mater University of Sydney
Monash University
University of Melbourne
OccupationPsychiatrist
Organization(s)Orygen, The National Centre of Excellence in Youth Mental Health
Known forDevelopment of the early intervention services for youth psychosis
Title Australian of the Year
Term2010
Predecessor Mick Dodson
Successor Simon McKeon
Spouse
Merilyn Hawke
​
(m. 1980)​
ChildrenThree
Awards Order of Australia
Website www.patmcgorry.com.au

Patrick Dennistoun McGorry [1] AO FAA FASSA FAHMS FRCP FRANZCP (born 10 September 1952) is an Irish-born Australian psychiatrist known for his development of the early intervention services for emerging mental disorders in young people.

Contents

Position

McGorry is Professor of Youth Mental Health at the University of Melbourne. [2] He has written more than 640 peer-reviewed articles with more than 56810 citations, published in journals including The Lancet , the British Journal of Psychiatry , the American Journal of Psychiatry and the Medical Journal of Australia. [3] He is executive director of Orygen, The National Centre of Excellence in Youth Mental Health [4] and founding editor of Early Intervention in Psychiatry published by the International Early Psychosis Association. McGorry also advocated strongly for the establishment of the Australian government funded National Youth Mental Health Foundation, which became headspace, and is a founding board member of that organisation. [5] McGorry played a key role in leading the design, advocacy and scaling up of headspace services.

Early intervention in psychosis

McGorry and his colleagues developed an approach for young people who have symptoms of psychosis for the first time, based at the EPPIC clinic in Melbourne. [6] This EPPIC clinic has played a key part in an early psychosis treatment paradigm for psychiatry [7] [8] [9] and has led to significant reform of mental health services, [10] especially in the United Kingdom. [11] The EPPIC program's approach is best represented by the catch phrase "A stitch in time." [12] A linked development is the PACE clinic: a service for young people with sub-threshold symptoms who are at risk of developing psychosis. [13]

Initial evaluations of EPPIC showed that it was not only effective compared to the previous traditional model of care but that it was also cost effective. [14] [15] [16] [17] McGorry was awarded the Centenary Medal in 2003 in recognition of his work on the EPPIC program. [18]

McGorry has also led research and new models of care for early intervention with young people who seek help for symptoms and impairment, and are known to be at risk for more severe psychosis, but whose psychotic symptoms are less intense, including the use of safer interventions than antipsychotic medication. [19] He has generated a body of research to determine the correct sequence of treatment, that includes psychosocial interventions. [20] [21] [22]

McGorry has advocated to the Australian government to create a national network of early psychosis intervention centres, based on evidence that early treatment may improve long-term outcomes. [23] He has worked with all sides of politics in Australia to establish and improve early psychosis services. The early psychosis model of care has garnered bipartisan support, and was originally funded under the Gillard Labor government in 2011.

Criticisms

McGorry has faced a number of criticisms of his work.

Early intervention for psychosis was initially met with resistance due to a claimed lack of evidence. In 2011, a systematic review concluded: "There is some support for specialised early intervention services, but further trials would be desirable, and there is a question of whether gains are maintained." [24] Some critics have argued that McGorry has exaggerated the evidence for early intervention and that long-term benefits and economic savings have not been established, [25] [26] [27] [28] [29] [30] [31] and one has gone as far as alleging that McGorry has "systematically misled" the Australian Government about the nature and implications of his evaluation study on EPPIC by misstating the description of the control group. [32]

Since these criticisms were made further evidence has accumulated. Cochrane level 1 evidence now exists demonstrating the effectiveness of early intervention for first episode psychosis [33] and for those at ultra-high risk for psychosis. [34] Early intervention services for psychosis have been effective in reducing mortality rates [35] and providing a return on investment. [36] They are also a preferred service model for consumers. [37] In the past two decades evaluations in England and Denmark have shown that early intervention is effective over the first two years of care at least, but when patients return to traditional care some of the gains are lost. [38] [39] Canadian data indicates that if patients remain in early intervention services for five years the gains are sustained. [40] [41]

McGorry's views on giving antipsychotic medication to at-risk young people have been criticised by a number of people, including Allen Frances the Chair of the DSM-IV Taskforce, on the basis that most at-risk young people will not become psychotic and pre-emptive treatment may be risky. [42] [43] [44] McGorry and his colleagues have responded to this criticism, arguing that critics have blurred the key distinction between clinical recommendations and ethically approved research designed to build evidence to more firmly guide clinical practice. [45] [46] [47] A proposed trial of the antipsychotic medication quetiapine, led by McGorry, attracted criticism on ethical grounds. [48] [49] McGorry is published advocating for psychosocial strategies as a first-line intervention. [50]

He has been accused of having a conflict of interest in using his position on a government advisory committee to advocate for programs that he founded. [51] McGorry has denied that he has any conflict of interest and a spokesperson for the Australian government stated that McGorry was just one member of the Mental Health Expert Working Group, which was made up of experts from a range of health and non-health sectors, plus consumer and carer representatives and 'while these consultations helped to inform the development of the government’s record mental health package, decisions on the specific content...were solely a matter for the government'. [52] On 25 September 2012, Western Australian member of parliament Martin Whitely made a speech in parliament criticising the Australian Government for its support of McGorry's proposals. Whitely said that McGorry had made overblown claims for his programs and that they had been accepted without proper scrutiny. [53] These criticisms are not supported by current evidence. [54] [55]

Headspace

Early intervention in psychosis has paved the way for a broader model of care ("headspace") that targets a range of youth mental disorders. McGorry was a key architect of the headspace model, which has been replicated internationally. [56] Headspace was originally founded under the Howard government with its support continuing under the Gillard government. Its design and national rollout has gained bipartisan support. During the 2013 Australian Federal election, McGorry appeared in the media together with then Opposition Leader Tony Abbott at the launch of the Liberal-National Coalition's mental health policy. Abbott promised that, if elected, he would provide additional financial support for research and translation programs associated with Patrick McGorry. [57] After being elected to government, the Coalition announced in its first budget the allocation of $18M over 4 years to Orygen Youth Health Research Centre for establishment of a National Centre of Excellence in Youth Mental Health and $14.9M to headspace for the expansion of its youth mental health services. [58] In 2018 the Turnbull government committed to a three-year extension of funding ($13.5 million) to Orygen, The National Centre of Excellence in Youth Mental Health, and also committed an additional $30 million to headspace. [59]

Although the headspace model has faced some criticism, its evidence-based benefits include improved service access and engagement, and modest improvements in outcomes compared to standard care. [60] The success of headspace has seen it grow from 10 centres in 2007 to 110 in 2018 that are accessed by 100,000 young people each year, with an additional 30,000 accessing its online service eheadspace. The headspace model is currently being enhanced to improve service provision. It has been influential in several other nations in youth mental health reform, notably Ireland, Canada, Israel, Denmark and the Netherlands.[ citation needed ]

Recognition and other activities

In January 2010 McGorry was named Australian of the Year for his services to youth mental health. [61] [62] [63] In June 2010 he was appointed an Officer of the Order of Australia. [64]

In 2013 McGorry was honoured with the National Alliance on Mental Illness Scientific Research Award, the first time the award has been bestowed upon a researcher outside of the United States. [65]

In 2015, McGorry was awarded the Lieber Prize for Outstanding Achievement in Schizophrenia Research, given by the Brain & Behavior Research Foundation. [66]

In 2018 he was awarded the Lifetime Achievement Award by the Schizophrenia International Research Society. [67] He was the first psychiatrist elected as a Fellow of the Australian Academy of Science. [68]

McGorry served as President of the Society for Mental Health Research (Australia) (2013-2017), Schizophrenia International Research Society (2016-2018), and International Early Psychosis Association (1997-2006). As of 2018 he was president of the International Association for Youth Mental Health. He is a member of many advisory committees both nationally and internationally, including the Million Minds Mission for mental health launched by the Australian Government in 2018. [69] He is a co-founder of Australians for Mental Health and serves on its board of directors.[ citation needed ]

McGorry is an ambassador for the Beehive Foundation, an Australian charity that provides resilience programs for young people.[ citation needed ]

On 10 October 2023, McGorry initiated and was one of 25 Australians of the Year who signed an open letter supporting the Yes vote in the Indigenous Voice referendum. He said he was driven to do so out of fear for the damage to mental health that Indigenous Australians would suffer if the Voice is rejected. [70] [71]

Related Research Articles

<span class="mw-page-title-main">Antipsychotic</span> Class of medications

Antipsychotics, also known as neuroleptics, are a class of psychotropic medication primarily used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders. They are also the mainstay together with mood stabilizers in the treatment of bipolar disorder.

<span class="mw-page-title-main">Cognitive behavioral therapy</span> Therapy to improve mental health

Cognitive behavioral therapy (CBT) is a psycho-social intervention that aims to reduce symptoms of various mental health conditions, primarily depression and anxiety disorders. Cognitive behavioral therapy is one of the most effective means of treatment for substance abuse and co-occurring mental health disorders. CBT focuses on challenging and changing cognitive distortions and their associated behaviors to improve emotional regulation and develop personal coping strategies that target solving current problems. Though it was originally designed to treat depression, its uses have been expanded to include many issues and the treatment of many mental health conditions, including anxiety, substance use disorders, marital problems, ADHD, and eating disorders. CBT includes a number of cognitive or behavioral psychotherapies that treat defined psychopathologies using evidence-based techniques and strategies.

Psychosis is a condition of the mind that results in difficulties determining what is real and what is not real. Symptoms may include delusions and hallucinations, among other features. Additional symptoms are incoherent speech and behavior that is inappropriate for a given situation. There may also be sleep problems, social withdrawal, lack of motivation, and difficulties carrying out daily activities. Psychosis can have serious adverse outcomes.

<span class="mw-page-title-main">Schizophrenia</span> Mental disorder with psychotic symptoms

Schizophrenia is a mental disorder characterized by continuous or relapsing episodes of psychosis. Major symptoms include hallucinations, delusions and disorganized thinking. Other symptoms include social withdrawal and flat affect. Symptoms typically develop gradually, begin during young adulthood, and in many cases are never resolved. There is no objective diagnostic test; diagnosis is based on observed behavior, a psychiatric history that includes the person's reported experiences, and reports of others familiar with the person. For a diagnosis of schizophrenia, the described symptoms need to have been present for at least six months or one month. Many people with schizophrenia have other mental disorders, especially substance use disorders, depressive disorders, anxiety disorders and obsessive–compulsive disorder.

Richard Bentall is a Professor of Clinical Psychology at the University of Sheffield in the UK.

Schizotypal personality disorder, also known as schizotypal disorder, is a cluster A personality disorder. The Diagnostic and Statistical Manual of Mental Disorders (DSM) classification describes the disorder specifically as a personality disorder characterized by thought disorder, paranoia, a characteristic form of social anxiety, derealization, transient psychosis, and unconventional beliefs. People with this disorder feel pronounced discomfort in forming and maintaining social connections with other people, primarily due to the belief that other people harbor negative thoughts and views about them. Peculiar speech mannerisms and socially unexpected modes of dress are also characteristic. Schizotypal people may react oddly in conversations, not respond, or talk to themselves. They frequently interpret situations as being strange or having unusual meanings for them; paranormal and superstitious beliefs are common. Schizotypal people usually disagree with the suggestion that their thoughts and behaviors are a 'disorder' and seek medical attention for depression or anxiety instead. Schizotypal personality disorder occurs in approximately 3% of the general population and is more commonly diagnosed in males.

The Hearing Voices Movement (HVM) is the name used by organizations and individuals advocating the "hearing voices approach", an alternative way of understanding the experience of those people who "hear voices". In the medical professional literature, ‘voices’ are most often referred to as auditory verbal hallucinations. The movement uses the term ‘hearing voices’, which it feels is a more accurate and 'user-friendly' term.

<span class="mw-page-title-main">Jim van Os</span> Dutch psychiatrist and epidemiologist

Jim van Os is a Dutch academic and psychiatrist. He is Professor of Psychiatry and medical manager of the Brain Center at Utrecht University Medical Center, the Netherlands.

People with schizophrenia are at a higher than average risk of physical ill health, and earlier death than the general population. The fatal conditions include cardiovascular, respiratory and metabolic disorders.

The management of schizophrenia usually involves many aspects including psychological, pharmacological, social, educational, and employment-related interventions directed to recovery, and reducing the impact of schizophrenia on quality of life, social functioning, and longevity.

In medicine, a prodrome is an early sign or symptom that often indicates the onset of a disease before more diagnostically specific signs and symptoms develop. It is derived from the Greek word prodromos, meaning "running before". Prodromes may be non-specific symptoms or, in a few instances, may clearly indicate a particular disease, such as the prodromal migraine aura.

<span class="mw-page-title-main">Mental health literacy</span>

Mental health literacy has been defined as "knowledge and beliefs about mental disorders which aid their recognition, management and prevention. Mental health literacy includes the ability to recognize specific disorders; knowing how to seek mental health information; knowledge of risk factors and causes, of self-treatments, and of professional help available; and attitudes that promote recognition and appropriate help-seeking". The concept of mental health literacy was derived from health literacy, which aims to increase patient knowledge about physical health, illnesses, and treatments.

Early intervention in psychosis is a clinical approach to those experiencing symptoms of psychosis for the first time. It forms part of a new prevention paradigm for psychiatry and is leading to reform of mental health services, especially in the United Kingdom and Australia.

The International Early Psychosis Association (IEPA) is a professional body and international network for those with a professional interest in early intervention in mental health and early psychosis intervention.

At risk mental state is the clinical presentation of those considered at risk of developing psychosis or schizophrenia. Such states were formerly considered treated as prodromes, emerging symptoms of psychosis, but this view is no longer prevalent as a prodromal period can not be confirmed unless the emergence of the condition has occurred.

IPS Supported Employment is an evidence-based approach to supported employment for people who have a mental illness. IPS stands for Individual Placement and Support. IPS supports people in their efforts to achieve steady, meaningful employment in mainstream competitive jobs, either part-time or full-time. This stands in contrast to other vocational rehabilitation approaches that employ people in sheltered workshops and other set-aside jobs.

<span class="mw-page-title-main">Basic symptoms of schizophrenia</span> Subjective symptoms of schizophrenia

Basic symptoms of schizophrenia are subjective symptoms, described as experienced from a person's perspective, which show evidence of underlying psychopathology. Basic symptoms have generally been applied to the assessment of people who may be at risk to develop psychosis. Though basic symptoms are often disturbing for the person, problems generally do not become evident to others until the person is no longer able to cope with their basic symptoms. Basic symptoms are more specific to identifying people who exhibit signs of prodromal psychosis (prodrome) and are more likely to develop schizophrenia over other disorders related to psychosis. Schizophrenia is a psychotic disorder, but is not synonymous with psychosis. In the prodrome to psychosis, uncharacteristic basic symptoms develop first, followed by more characteristic basic symptoms and brief and self-limited psychotic-like symptoms, and finally the onset of psychosis. People who were assessed to be high risk according to the basic symptoms criteria have a 48.5% likelihood of progressing to psychosis. In 2015, the European Psychiatric Association issued guidance recommending the use of a subscale of basic symptoms, called the Cognitive Disturbances scale (COGDIS), in the assessment of psychosis risk in help-seeking psychiatric patients; in a meta-analysis, COGDIS was shown to be as predictive of transition to psychosis as the Ultra High Risk (UHR) criteria up to 2 years after assessment, and significantly more predictive thereafter. The basic symptoms measured by COGDIS, as well as those measured by another subscale, the Cognitive-Perceptive basic symptoms scale (COPER), are predictive of transition to schizophrenia.

Prevention of mental disorders are measures that try to decrease the chances of a mental disorder occurring. A 2004 WHO report stated that "prevention of these disorders is obviously one of the most effective ways to reduce the disease burden." The 2011 European Psychiatric Association (EPA) guidance on prevention of mental disorders states "There is considerable evidence that various psychiatric conditions can be prevented through the implementation of effective evidence-based interventions." A 2011 UK Department of Health report on the economic case for mental health promotion and mental illness prevention found that "many interventions are outstandingly good value for money, low in cost and often become self-financing over time, saving public expenditure". In 2016, the National Institute of Mental Health re-affirmed prevention as a research priority area.

Metacognitive training (MCT) is an approach for treating the symptoms of psychosis in schizophrenia, especially delusions, which has been adapted for other disorders such as depression, obsessive–compulsive disorder and borderline over the years. It was developed by Steffen Moritz and Todd Woodward. The intervention is based on the theoretical principles of cognitive behavioral therapy, but focuses in particular on problematic thinking styles that are associated with the development and maintenance of positive symptoms, e.g. overconfidence in errors and jumping to conclusions. Metacognitive training exists as a group training (MCT) and as an individualized intervention (MCT+).

<span class="mw-page-title-main">Paolo Fusar-Poli</span> Italian medical doctor, psychiatrist

Paolo Fusar-Poli is an Italian and British medical doctor, psychiatrist, and Professor at the Institute of Psychiatry, Psychology and Neuroscience, King's College, London and at the Department of Brain and Behavioral Sciences, University of Pavia.

References

  1. ↑ "University Secretar's Department Lists of Members – Professors Emeritus The University of Melbourne". www.unimelb.edu.au. Retrieved 29 January 2010.
  2. ↑ "Patrick McGorry (Australia)". International Early Psychosis Association. Archived from the original on 6 July 2011. Retrieved 25 January 2010.
  3. ↑ "Patrick McGorry". Google Scholar. Retrieved 17 July 2018.
  4. ↑ Orygen, The National Centre of Excellence in Youth Mental Health orygen.org.au, Retrieved 22 October 2014
  5. ↑ headspace. "headspace Board". Archived from the original on 10 January 2014. Retrieved 10 January 2014.
  6. ↑ McGorry PD; Edwards J; Mihalopoulos C; Harrigan SM; Jackson HJ (1996). "EPPIC: an evolving system of early detection and optimal management". Schizophrenia Bulletin . 22 (2): 305–326. doi: 10.1093/schbul/22.2.305 . PMID   8782288.
  7. ↑ Edwards, J. & McGorry, P.D. (2002) (eds). Implementing Early Intervention in Psychosis. A guide to establishing early psychosis services. London. Martin Dunitz.
  8. ↑ McGorry PD, Killackey EJ (2002). "Early intervention in psychosis: a new evidence based paradigm". Epidemiol Psychiatr Sci. 11 (4): 237–47. doi:10.1017/s1121189x00005807. PMID   12585014. S2CID   11005414.
  9. ↑ McGorry PD, Killackey E, Yung A (October 2008). "Early intervention in psychosis: concepts, evidence and future directions". World Psychiatry. 7 (3): 148–56. doi:10.1002/j.2051-5545.2008.tb00182.x. PMC   2559918 . PMID   18836582.
  10. ↑ Killackey E, Yung AR, McGorry PD (2007). "Early psychosis: where we've been, where we still have to go". Epidemiol Psychiatr Sci. 16 (2): 102–8. doi: 10.1017/S1121189X0000470X . PMID   17619539.
  11. ↑ Joseph R, Birchwood M (September 2005). "The national policy reforms for mental health services and the story of early intervention services in the United Kingdom" (PDF). J Psychiatry Neurosci. 30 (5): 362–5. PMC   1197282 . PMID   16151542. Archived from the original (PDF) on 17 November 2015. Retrieved 27 January 2010.
  12. ↑ McGorry, P. D. (1998). ""A stitch in time"… the scope for preventive strategies in early psychosis". European Archives of Psychiatry and Clinical Neuroscience. 248 (1): 22–31. doi:10.1007/s004060050014. PMID   9561350. S2CID   7621618.
  13. ↑ Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A (1996). "Monitoring and care of young people at incipient risk of psychosis". Schizophr Bull. 22 (2): 283–303. doi: 10.1093/schbul/22.2.283 . PMID   8782287.
  14. ↑ McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ (1996). "EPPIC: an evolving system of early detection and optimal management". Schizophrenia Bulletin. 22 (2): 305–26. doi: 10.1093/schbul/22.2.305 . PMID   8782288.
  15. ↑ Mihalopoulos C, McGorry PD, Carter RC (1999). "Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome?". Acta Psychiatrica Scandinavica. 100 (1): 47–55. doi: 10.1111/j.1600-0447.1999.tb10913.x . PMID   10442439. S2CID   24815565.
  16. ↑ Mihalopoulos C, Harris M, Henry L, Harrigan S, McGorry P (May 2011). "Is early intervention in psychosis cost-effective over the long term?". Schizophrenia Bulletin. 35 (5): 909–18. doi:10.1093/schbul/sbp054. PMC   2728818 . PMID   19509308.
  17. ↑ McCrone P, Craig TK, Power P, Garety PA (2010). "Cost-effectiveness of an early intervention service for people with psychosis". The British Journal of Psychiatry. 196 (5): 377–82. doi: 10.1192/bjp.bp.109.065896 . PMID   20435964.
  18. ↑ "Professor Patrick D. McGorry (AO, MD, PhD, FRCP, FRANZCP)". Our Research: Research Leaders. Orygen Youth Health. Archived from the original on 3 December 2013. Retrieved 30 November 2013.
  19. ↑ McGorry, P.D. (2009). "Intervention in individuals at ultra-high risk for psychosis: a review and future directions". Journal of Clinical Psychiatry. 70 (9): 1206–1212. doi:10.4088/jcp.08r04472. PMID   19573499.
  20. ↑ McGorry, PD; et al. (2017). "Effect of ω-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: the NEURAPRO randomized clinical trial". JAMA Psychiatry. 74 (1): 19–27. doi: 10.1001/jamapsychiatry.2016.2902 . hdl: 10536/DRO/DU:30150863 . PMID   27893018.
  21. ↑ McGorry, PD; et al. (2013). "Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome". Journal of Clinical Psychiatry. 74 (4): 349–56. doi:10.4088/JCP.12m07785. PMID   23218022.
  22. ↑ McGorry, PD; et al. (2002). "Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms". Archives of General Psychiatry. 59 (10): 921–928. doi: 10.1001/archpsyc.59.10.921 . hdl: 10536/DRO/DU:30151296 . PMID   12365879.
  23. ↑ Vincent, M. (2011). Budget provides mental health relief. AM, 11 May 2011. http://www.abc.net.au/am/content/2011/s3213405.htm
  24. ↑ Marshall, M; Rathbone, J (2011). "Early intervention for psychosis". Cochrane Database of Systematic Reviews. 6 (6): CD004718. doi:10.1002/14651858.CD004718.pub3. PMC   4163966 . PMID   21678345.
  25. ↑ Creagh, S. (2011). Review finds limited evidence for early psychosis intervention centres. The Conversation,, 30 June 2011. http://theconversation.edu.au/review-finds-limited-evidence-for-early-intervention-in-psychosis-2091
  26. ↑ Bosanac, P.; Patton, G.C.; Castle, D.J. (2010). "Early intervention in psychotic disorders: faith before facts?". Psychological Medicine. 40 (3): 353–358. doi: 10.1017/s0033291709990341 . hdl: 11343/32983 . PMID   20120515.
  27. ↑ Amos, A (2012). "Assessing the cost of early intervention in psychosis: a systematic review". Australian & New Zealand Journal of Psychiatry. 46 (8): 719–734. doi:10.1177/0004867412450470. PMID   22696550. S2CID   27598337.
  28. ↑ Amos, A (2013). "An axeman in the cherry orchard: Early intervention rhetoric distorts public policy". Australian & New Zealand Journal of Psychiatry. 47 (4): 317–320. doi:10.1177/0004867412471438. PMID   23568159. S2CID   8198295.
  29. ↑ Orygen Youth Health Research Centre (2011) Early Psychosis Feasibility Study. Canberra: National Advisory Council on Mental Health
  30. ↑ Raven, M. (2011). Evaluating evidence for Early Psychosis Prevention and Intervention Centres (EPPIC). The Conversation 2 November 2011. http://www.theconversation.edu.au/evaluating-evidence-for-early-psychosis-prevention-and-intervention-centres-eppic-3604
  31. ↑ Amos, A (August 2012). "Assessing the cost of early intervention in psychosis: a systematic review". Aust N Z J Psychiatry. 46 (8): 719–34. doi:10.1177/0004867412450470. PMID   22696550. S2CID   27598337.
  32. ↑ Raven, M (2013). "EPPIC mirage: cost-effectiveness of early psychosis intervention". Aust N Z J Psychiatry. 47 (7): 599–601. doi:10.1177/0004867413484598. PMID   23814149. S2CID   28833438.
  33. ↑ Correll, CU; et al. (2018). "Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression". JAMA Psychiatry. 75 (6): 555–565. doi:10.1001/jamapsychiatry.2018.0623. PMC   6137532 . PMID   29800949.
  34. ↑ van der Gaag, M; et al. (2013). "Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups". Schizophrenia Research. 149 (1–3): 56–62. doi:10.1016/j.schres.2013.07.004. PMID   23870806. S2CID   8093620.
  35. ↑ Anderson, KK; et al. (2018). "Effectiveness of early psychosis intervention: comparison of service users and nonusers in population-based health administrative data". American Journal of Psychiatry. 175 (5): 443–452. doi: 10.1176/appi.ajp.2017.17050480 . PMID   29495897.
  36. ↑ Campion, J; Knapp, M (2018). "The economic case for improved coverage of public mental health interventions". Lancet Psychiatry. 5 (2): 103–105. doi:10.1016/S2215-0366(17)30433-9. PMID   29129595.
  37. ↑ Schizophrenia Commission (2012). The Abandoned Illness: A report by the Schizophrenia Commission. Archived from the original on 11 July 2018. Retrieved 17 July 2018.
  38. ↑ Craig TK, Garety P, Power P, Rahaman N, Colbert S, Fornells-Ambrojo M, Dunn, G (2004). "The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis". British Medical Journal. 329 (7474): 1067. doi:10.1136/bmj.38246.594873.7c. PMC   526115 . PMID   15485934.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  39. ↑ Petersen L, Jeppesen P, Thorup A, Abel MB, Ohlenschlaeger J, Christensen, TO, Krarup, G, Jorgensen P, Nordentoft, M (2005). "A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness". British Medical Journal. 331 (7517): 602. doi:10.1136/bmj.38565.415000.E01. PMC   1215551 . PMID   16141449.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  40. ↑ Norman R, Manchanda R, Malla A, Windell D, Harricharan R, Northcott S (2011). "Symptom and functional outcomes for a 5-year early intervention program for psychoses". Schizophrenia Research. 129 (2–3): 111–15. doi:10.1016/j.schres.2011.04.006. PMID   21549566. S2CID   32425393.
  41. ↑ Malla, A; et al. (2017). "Comparing three-year extension of early intervention service to regular care following two years of early intervention service in first-episode psychosis: a randomized single blind clinical trial". World Psychiatry. 16 (3): 278–286. doi:10.1002/wps.20456. PMC   5608831 . PMID   28941098.
  42. ↑ Frances, A (2010). "Psychosis risk syndrome—far too risky?". Australian and New Zealand Journal of Psychiatry. 45 (10): 803–804. doi: 10.3109/00048674.2011.614217 . PMID   21910651.
  43. ↑ Dunlevy, S. (2011). US expert slams McGorry's psychosis model. The Australian, 14 June 2011. http://www.theaustralian.com.au/national-affairs/us-expert-slams-patrick-mcgorrys-psychosis-model/story-fn59niix-1226074544901
  44. ↑ Jorm, AF (September 2012). "Ethics of giving antipsychotic medication to at-risk young people". Aust N Z J Psychiatry. 46 (9): 908–9. doi:10.1177/0004867412455233. PMID   22802552. S2CID   206398433.
  45. ↑ McGorry, P (April 2012). "Truth and reality in early intervention". Australian and New Zealand Journal of Psychiatry. 46 (4): 313–316. doi:10.1177/0004867412442172. PMID   22508591. S2CID   206398119.
  46. ↑ McGorry, P (March 2012). "At issue: Cochrane, early intervention, and mental health reform: analysis, paralysis, or evidence-informed progress?". Schizophrenia Bulletin. 38 (2): 221–224. doi:10.1093/schbul/sbr185. PMC   3283140 . PMID   22247539.
  47. ↑ McGorry, P (July 2011). "Pre-emptive intervention in psychosis: agnostic rather than diagnostic". Australian and New Zealand Journal of Psychiatry. 45 (7): 515–519. doi: 10.3109/00048674.2011.581648 . PMID   21718121. S2CID   8467492.
  48. ↑ Stark, J. (2011). Drug trial scrapped amid outcry. The Age, 21 August 2011. http://www.theage.com.au/national/drug-trial-scrapped-amid-outcry-20110820-1j3vy.html.
  49. ↑ Raven, M.; Stuart, G.W.; Jureidini, J. (2012). "'Prodromal' diagnosis of psychosis: ethical problems in research and clinical practice". Australian and New Zealand Journal of Psychiatry. 46 (1): 64–65. doi:10.1177/0004867411428917. PMID   22247095. S2CID   206397893.
  50. ↑ McGorry, PD; et al. (2013). "Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome". Journal of Clinical Psychiatry. 74 (4): 349–56. doi:10.4088/JCP.12m07785. PMID   23218022.
  51. ↑ Stark, J. (2011). McGorry accused of conflict of interest. Sydney Morning Herald 7 August 2011. http://www.smh.com.au/national/mcgorry-accused-of-conflict-of-interest-20110806-1igxd.html
  52. ↑ Thompson, J. McGorry’s mental health minefield. Medical Observer, 6 October 2011. http://www.medicalobserver.com.au/news/mcgorrys-mental-health-minefield?print=friendly
  53. ↑ Dunlevy, S. (2012). Doubts cast on youth mental health program. Herald Sun 7 October 2012. http://www.heraldsun.com.au/news/national/doubts-cast-on-youth-mental-health-program/story-fndo48ca-1226489760605
  54. ↑ Correll, CU; et al. (2018). "Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression". JAMA Psychiatry. 75 (6): 555–565. doi:10.1001/jamapsychiatry.2018.0623. PMC   6137532 . PMID   29800949.
  55. ↑ van der Gaag, M; et al. (2013). "Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups". Schizophrenia Research. 149 (1–3): 56–62. doi:10.1016/j.schres.2013.07.004. PMID   23870806. S2CID   8093620.
  56. ↑ McGorry, PD; Goldstone, SD; Parker, AG; Rickwood, DJ; Hickie, IB (2014). "Cultures for mental health care of young people: an Australian blueprint for reform". Lancet Psychiatry. 1 (7): 559–568. doi:10.1016/S2215-0366(14)00082-0. PMID   26361315.
  57. ↑ "Mental health is largely missing from the election campaign". The Conversation. 2 September 2013. Retrieved 12 August 2018.
  58. ↑ "Expense Measures (Health)". Australian Government budget 2014-15. Australian Government. Archived from the original on 11 November 2018. Retrieved 12 August 2018.
  59. ↑ "$110 million additional investment in child and youth mental health". The Hon Greg Hunt MP Minister for Health. Australian Government Department of Health. Retrieved 12 August 2018.
  60. ↑ Hilferty, F; Cassells, R; Muir, K; Duncan, A; Christensen, D; Mitrou, F; Gao, G; Mavisakalyan, A; Hafekost, K; Tarverdi, Y; Nguyen, H; Wingrove, C; Katz, I (August 2015). Is headspace making a difference to young people's lives? Final Report of the independent evaluation of the headspace program. Sydney: Social Policy Research Centre, UNSW Australia.
  61. ↑ "Mental health expert is Australian of the Year". ABC. 25 January 2009.
  62. ↑ "Australian of the Year 2010". australianoftheyear.org.au. Archived from the original on 28 January 2010. Retrieved 25 January 2010.
  63. ↑ Lewis, Wendy (2010). Australians of the Year. Pier 9 Press. ISBN   978-1-74196-809-5.
  64. ↑ It's an Honour: Officer of the Order of Australia
  65. ↑ NAMI. "2013 Research Award". Archived from the original on 3 October 2013. Retrieved 9 January 2014.
  66. ↑ "Meet the 2015 Outstanding Achievement Prize Winners". Brain & Behavior Research Foundation. Archived from the original on 11 September 2016. Retrieved 29 August 2016.
  67. ↑ "Awards and Grants". Schizophrenia International Research Society. Retrieved 12 August 2018.
  68. ↑ "Professor Patrick McGorry". Australian Academy of Science. Retrieved 12 August 2018.
  69. ↑ "Setting up a research fund for mental health: Greg Hunt". Australian Broadcasting Corporation. 6 March 2018. Retrieved 12 August 2018.
  70. ↑ Butler, Josh (11 October 2023). "Australian of the Year winners sign open letter saying no vote in voice referendum would be a 'shameful dead end'". The Guardian . Retrieved 11 October 2023.
  71. ↑ Winter, Velvet (10 October 2023). "Voice referendum live updates: Australians of the Year Yes vote letter in full". ABC News (Australia) . Retrieved 11 October 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.